Belpointe Asset Management’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16
Closed -$796 1089
2023
Q1
$796 Hold
16
﹤0.01% 3512
2022
Q4
$962 Buy
+16
New +$1.24K ﹤0.01% 3445

Other funds holding CNBS

Belpointe Asset Management's CNBS Position: Q2 2023 in Review

Belpointe Asset Management sold out of Amplify Seymour Cannabis ETF (CNBS) in Q2 2023, closing a stake of 16 shares — an estimated $796 sold.

Belpointe Asset Management first reported a position in CNBS in Q4 2022 and held it in 2 quarters. The position peaked at $962 in Q4 2022. 26 funds tracked by Wall St. Rank hold CNBS as of Q2 2023.

  • Belpointe Asset Management reported no remaining Amplify Seymour Cannabis ETF position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 16 Amplify Seymour Cannabis ETF shares in Q2 2023, an estimated $796.
  • Belpointe Asset Management first reported a position in Amplify Seymour Cannabis ETF in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Amplify Seymour Cannabis ETF position peaked at $962 in Q4 2022.
  • 26 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.